1. An Uncommon Case of Pediatric Esthesioneuroblastoma Presenting as SIADH: 18F-FDG PET/CT in Staging and Post-Therapeutic Assessment
   Marie Fosbøl et al, 2018, Diagnostics CrossRef
2. Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory Esthesioneuroblastoma
   Julia R Schneider et al, 2018, Operative Neurosurgery CrossRef
3. Molecular imaging and therapy of somatostatin receptor positive tumors
   Jana Ivanidze et al, 2019, Clinical Imaging CrossRef
4. DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair
   Yousef Khazaei Monfared et al, 2023, Pharmaceutics CrossRef
5. Ga-68 DOTATATE Positron Emission Tomography/Computed Tomography in a Rare Case of Esthesioneuroblastoma
   Priyanka Verma et al, 2021, Indian Journal of Nuclear Medicine CrossRef
6. Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma
   Olfat Kamel Hasan et al, 2020, Journal of Nuclear Medicine CrossRef
7. PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology
   Richard H. Wiggins et al, 2022, Cancers CrossRef
8. Doing Great With DOTATATE
   Avraham B. Zlochower et al, 2021, Topics in Magnetic Resonance Imaging CrossRef
9. Olfactory Neuroblastoma: Treatment Strategies for Advanced Disease
   Lucas P. Carlstrom et al, 2023, Current Otorhinolaryngology Reports CrossRef
10. A prospective cohort study on stereotactic radiotherapy in the management of dural recurrence of olfactory neuroblastoma
    Christopher D. Goodman et al, 2024, Head & Neck CrossRef
11. Update on radionuclide therapy in oncology (Review)
    Cornelia Nitipir et al, 2017, Oncology Letters CrossRef
12. 68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region
    Habibollah Dadgar et al, 2020, Clinical Nuclear Medicine CrossRef
13. 172Hf → 172Lu Radionuclide Generator Based on a Reverse-Tandem Separation Scheme
    J. A. Dadakhanov et al, 2018, Radiochemistry CrossRef
14. Feasibility and Therapeutic Potential of Combined Peptide Receptor Radionuclide Therapy With Intensive Chemotherapy for Pediatric Patients With Relapsed or Refractory Metastatic Neuroblastoma
    Gholamreza Fathpour et al, 2021, Clinical Nuclear Medicine CrossRef
15. Imaging of Anterior and Central Skull Base Tumors: a Review
    Christopher M. Low et al, 2020, Current Otorhinolaryngology Reports CrossRef
16. [68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative cases
    Michelle Roytman et al, 2021, Journal of Neurosurgery: Case Lessons CrossRef
17. β-radiating radionuclides in cancer treatment, novel insight into promising approach
    Samieh Asadian et al, 2020, Pharmacological Research CrossRef
18. SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications
    Vincent Cracolici et al, 2021, Head and Neck Pathology CrossRef
19. Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas
    Jasmina Topcagic et al, 2018, PLOS ONE CrossRef
20. PET Imaging of Peripheral Nerve Tumors
    Majid Assadi et al, 2019, PET Clinics CrossRef
21. How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology
    Arian Lasocki et al, 2019, Cancer Imaging CrossRef